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ABSTRACT
Amphetamine (AMPH) is widely prescribed for the treatment of ADHD and a highly abused
substance in society, yet little is known about the long-term effects of the drug. Here, we used
Caenorhabditis elegans (C. elegans) to establish a model for the long-term and transgenerational
effects of AMPH exposure on behavior. Furthermore, experiments were conducted to explore the
molecular mechanisms of AMPH that were altered by embryonic AMPH exposure.

C. elegans have a well characterized behavioral response to AMPH known as Swimming
Induced Paralysis (SWIP). For the SWIP test, animals are placed in fluid, which normally
induces a thrashing behavior. However, in the presence AMPH, the animals display a time- and
dose-dependent paralysis. AMPH increases the levels of dopamine in the synapse by causing
reverse transport through the protein known as the dopamine transporter (DAT), and the SWIP
behavior has been shown to be dependent on dopaminergic transmission. We exposed embryos
to either control solution alone (M9 solution) or 500µM AMPH dissolved in control solution for
15 hours. 4 days later the SWIP test was performed on young adult animals, revealing that
animals previously exposed to AMPH as embryos displayed a higher response to AMPH. The
progeny of both groups were tested for SWIP as well. Interestingly, the progeny of the animals
exposed to AMPH as embryos showed a higher SWIP response with respect to the progeny of
control animals, demonstrating that AMPH had both a long-term and transgenerational effect on
the animals.
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Because the SWIP behavior was previously shown to be dependent on dopaminergic
transmission, we performed DA uptake assays using primary cell cultures made from F1
generation animals to investigate alterations in DATs ability to uptake dopamine. Results from
the uptake assays showed that primary cultures made from the progeny of animals exposed to
AMPH as embryos had reduced ability to uptake DA with respect to control cultures. To further
investigate the reduced uptake ability following AMPH exposure, a human neuroblastoma cell
line (SH-SY5Y) was exposed to 15 hour of AMPH, and 5 days later, a DA uptake assay using a
concentration response of DA was carried out. Results showed that the cells had a reduced Vmax
with no change to Km, suggesting a reduced amount of DAT in the cells.

We investigated changes in histone methylation as a mechanism for the long-term and
transgenerational effect observed. Histones are proteins, which DNA wraps around to form the
nucleosome, and methylation changes on histones can modify the binding of DNA to histones
leading to a change in gene expression. Western blots of whole animal protein revealed a
decreased level of histone 3 lysine 4 trimethylation (H3K4me3) in the F1 generation of AMPH
exposed animals. Additionally, a reduction in the enzymes responsible for H3K4me2
methylation and H3K4me3 demethylation was observed in F1 progeny of AMPH exposed
animals. Suggesting that AMPH exposure during embryogenesis alters methylation of specific
histone markers.

Taken together, these experiments show that in C. elegans, AMPH exposure causes a long-term
and transgenerational alteration in behavioral response to AMPH, which correlates to alterations
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in DAT uptake ability.
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INTRODUCTION
The Neuron and Neurotransmission
The primary cell types of the central nervous system are neurons, electrically excitable cells
which communicate from one to another, and the supporting cells known as glia. There are
several types of neurons, for instance, motor neurons responsible for communicating movement
commands, sensory neurons responsible for signaling from sensory organs, and interneurons
responsible for communicating between neurons. These cells typically consist of dendrites that
are the primary area for receiving signals, a cell body also referred to as soma, and an axon,
which sends electrical signals away from the soma for communication (Figure 1).

Image courtesy, US National Cancer Institute's Surveillance, Epidemiology and End Results
(SEER) Program
Figure 1: Structure of the neuron
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Neurons communicate with each other using electro-chemical signaling referred to as action
potentials. In order for a neuron to send signals to another neuron they will form a synapse
(Figure 2), a gap between the two cells that are very close but do not touch allowing for chemical
transmission. These communications occur in a unidirectional manner through action potentials.
Neurons at resting state are negatively charged typically around -70mV. This negative charge is
established by the action of the sodium-potassium pump (also known as Na+/K+-ATPase). This
protein is an antiporter, meaning it is a transporter, which moves 2 or more molecules in opposite
directions. The sodium-potassium pump moves 3 sodium ions outside of the cells while moving
2 potassium ions into the cell, each against their concentration gradient. When the culmination of
incoming signal depolarizes the neuron at the beginning of the axon known as the axon hillock,
to the threshold potential (normally around -55mV) an action potential is triggered. Once the
threshold potential is reached depolarization begins by voltage gated sodium channels located on
the axon opening and allowing sodium to move with its concentration gradient into the cell, thus
rapidly raising the membrane potential. Following a short period the voltage-gated sodium
channels will begin to close, and go through a refractory period in which they cannot re-open
which keeps the action potential from moving backwards. Additionally repolarization begins by
voltage gated potassium channels opening, at this point the membrane potential is positive which
causes the potassium ions to move out of the cell following their voltage and concentration
gradients. These positive charged potassium ions moving out of the cells leads to the membrane
potential lowering back toward resting potential.

As the action potential moves down the axon of the neurons it eventually reaches the end, known
as the terminal button. When the depolarization reaches the button it triggers voltage dependent
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calcium channels to open. This allows calcium to enter the cell. Within the button exist lipid
vesicles known as synaptic vesicles. Synaptic vesicles have a protein known as vesicular
monoamine transporter (VMAT), which transports neurotransmitters into the vesicle following
the synthesis of the neurotransmitter. Neurotransmitters are chemicals responsible for
transmitting the signal across the synapse. The entrance of calcium into the button begins the
process of the synaptic vesicles fusing to the membrane, which releases their content into the
synapse. The neurotransmitters released can then diffuse across the synapse to interact with
receptors on the postsynaptic cell.

Image courtesy, Thomas Splettstoesser
Figure 2: The synapse
Dopaminergic Transmission
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Dopaminergic transmission is significant in a number of physiological mechanisms including,
reinforcement of reward, mood, cognition, and fine-tuning of movement. Additionally, alteration
of dopaminergic transmission by addictive drugs has been shown to be the major process in the
cause of addiction. There are 4 major dopaminergic pathways in the brain, the mesolimbic,
mesocortical, nigrostriatal, and tuberoinfundibular.

The nigrostriatal pathway connects the substantia nigra to the caudate nucleus and putamen. This
pathway has long been studied for its role in fine-tuning of movement, additionally Parkinson
disease and other movement related disorders have been linked to disruption in this pathway	
  [1]
The hypothalamus is connected to the pituitary gland via the tuberoinfundibular pathway. This
pathway is important in regulating the release of prolactin [2]. The mesolimbic and mesocortical
pathways have long been studied for their role in addiction. The mesolimbic pathway projects
from the ventral tegmental area (VTA) to the nucleus accumbens, while the mesocortical
pathway projects from the VTA to the prefrontal cortex [3].

Dopamine is synthesized from tyrosine through a two-step enzymatic process (Figure 3). First Ltyrosine is taken up by neurons where it is converted to L-3,4-dihydroxyphenylalanine also
known as L-DOPA. The conversion from tyrosine to L-DOPA is carried out by the enzyme
tyrosine hydroxylase (TH) and this reaction is the rate-limiting step in process of synthesizing
dopamine. Next the enzyme aromatic amino acid decarboxylase (AADC) catalyzes the process
of turning L-DOPA into dopamine by removal of a carboxyl group from L-DOPA. Both TH and
AADC carry out their reactions to synthesize dopamine within the cytosol, following the
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synthesis of dopamine it must then be transported into synaptic vesicles by the protein vesicular
monoamine transporter (VMAT) [4].

Figure 3: Synthesis of dopamine. L-Tyrosine is converted to L-3,4-dihydroxyphenylalanine (LDOPA) by Tyrosine Hydroxylase (TH), followed by the conversion to dopamine by aromatic
amino acid decarboxylase (AADC).
The dopamine transporter (DAT) is a major protein in the regulation of dopamine levels within
the synapse because of its ability to uptake dopamine back into the presynaptic neuron. Once the
transporter reuptakes dopamine, the neurotransmitter can be recycled by being repackaged into
synaptic vesicles or broken down. DAT has 12 transmembrane domains and is from the SLC6A
family of transporters, which also includes the serotonin (SERT) and norepinephrine transporters
(NET). DAT acts as a symporter and uses the movement of Na+ and Cl- with their gradient to
translocate substrate [5, 6]. This is thought to happen through an alternating access mechanism
[7] in which the protein switches between inward facing and outward facing conformations,
binding substrate in one conformation and releasing that substrate after switching. In addition
DAT has been shown to have channel activity as well [8], which may also influence excitability
in DA neurons.
Psychostimulant Drugs
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Psychostimulant drugs such as AMPH, cocaine, or methylphenidate have a long history for their
use as therapeutic agents but are also carry with them the ability to cause addiction making them
an important subject of research. AMPH most common therapeutic use is to treat attention deficit
hyperactivity disorder (ADHD), although it is also used in the treatment of narcolepsy and
obesity. ADHD is characterized by a lack of concentration and shortened attention span, with
hyperactive mood. ADHD is commonly diagnosed in children and teenagers with the average
age of symptom onset being 7 [9], and typically treated with a single dose of AMPH every day.
This method of treatment of ADHD leads to long-term exposure to AMPH, the effects of which
have not been heavily studied.

AMPH also has a high potential for abuse especially when used recreationally. Additionally
there is no current pharmacological treatment for AMPH addiction [10], psychotherapy currently
being the only treatment.

AMPH and cocaine cause dependence by altering dopaminergic transmission, specifically
causing an increase in dopamine within the synaptic cleft. DAT blockers such as cocaine bind
the transporter in its outward facing conformation and stop the transporter from alternating to the
inward-facing conformation [11]. AMPH also can bind DAT and block DA reuptake, however
AMPH increases dopamine concentration within the synapse by causing reverse transport
through the dopamine transporter [12]. During this reverse transport, AMPH is translocated
inside the cell, where it can also cause reverse transport of dopamine through VMAT, emptying
the contents of the vesicles into the cytosol [13]. This cytosolic dopamine then continues to gets
reverse transported into the synapse by DAT. The dopamine can then act on the post-synaptic
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cell and concentrations stay elevated because dopamine is not being re-uptaken by DAT, and
levels of dopamine are only limited by diffusion.

Epigenetics Mechanisms of Amphetamine
Epigenetics refers to regulatory mechanisms that alter gene expression without altering DNA
sequence. The term means “above the gene” and includes a number of mechanisms, from
changes in chromatin structure such as histone modification, to direct methylation of DNA, and
interactions with non-coding RNA. Changes in environment, or in the context of these studies
exposure to drugs of abuse, can alter many of these mechanisms. The sum total of these
epigenetic changes in the cell is known as the epigenome, and more recently studies have begun
looking at the effects of epigenomic alterations following drug exposure on short and long-term
gene expression changes. While the study of epigenetic modifications following drug exposure
is a relatively new field, specific studies on AMPH have begun to show that both acute and
chronic exposure leads to epigenetic changes, which affect gene expression (Figure 4)	
  [14].

Histone modifications are one of the most studied epigenetic mechanisms for changes caused by
AMPH exposure. Histones are positively charged proteins that form a histone octamer core
composed of two copies of H2A, H2B, H3 and H4 proteins, which 147 base pairs of DNA wraps
around [15], the DNA and histone proteins together form what is called the nucleosome.
Nucleosomes are condensed into a structure known as chromatin [15]. The N-terminal tails of
histone proteins contain residues that can be modified in a number of ways such as methylation,
acetylation, phosphorylation, and ubiquitination. These modifications alter the interaction of the
histones with the DNA, which can lead to an open chromatin state known as euchromatin, that is
	
  

7	
  

associated with up regulated genes, or a closed chromatin state known as heterochromatin, which
is associated with down regulated genes.

The most commonly studied histone modification with relation to AMPH exposure has been
acetylation, the loss of which has been related to gene repression. One of the reasons for studies
in acetylation being more prevalent than other histone modifications is because of compounds
such as butyric acid (BA) and valproic acid (VPA). These drugs are histone deacetylase (HDAC)
inhibitors that readily cross the blood brain barrier, thus being valuable in investigating how
acetylation changes alter behavior.

Although HDAC inhibitors have been useful in studying how acetylation changes on specific
histones affects gene expression, there are discrepancies in the literature as to what effects
histone acetylation has on behavior. One group has found that HDAC inhibitors potentiate the
behavioral effects of AMPH [16, 17], while a number of studies have shown that HDAC
inhibitors reduce or block behavioral changes induced by AMPH [18-22]. These discrepancies
could be caused by a number of variables such as animal species, brain tissues investigated, or
treatment paradigms.

Alterations in histone methylation have been shown following exposure to drugs of abuse. While
less work has been done in this epigenetic mechanism with respect to AMPH, a previous paper
has shown that chronic AMPH treatment leads to changes in histone methylation, specifically
histone 3 lysine 9 dimethylation (H3K9me2), at the c-fos gene promoter [23]. c-fos has been
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studied highly with its relation to drugs of abuse; it is an immediate early gene that a number of
drugs have been shown to increase, including AMPH [24].

c-fos itself has a very interesting interaction with drugs of abuse. c-fos is a member of the FOS
family of transcription factors, which includes c-fos, FosB, and ΔFosB. Studies have shown that
c-fos has a varied expression depending on if AMPH treatment is acute or chronic. Acute
treatment of AMPH leads to an increase in c-fos expression [23, 25, 26], while chronic AMPH
treatment leads to a decrease in c-fos expression [23, 25]. However, after chronic treatment with
AMPH ΔFosB has been shown to increase [16, 23], and that increase persists even after
withdrawal. This has led to speculation that ΔFosB may have a big role in the development of
addiction to drugs [27-29]. The above-mentioned epigenetic mechanisms are believed to play a
big factor in this molecular switching, as it has been shown that acute AMPH treatment increased
H4 acetylation at the c-fos promoter, which fades after chronic AMPH treatments [23].

DNA methylation is also an epigenetic mechanism, which occurs when cytosine or adenine is
directly methylated on DNA. This methylation is associated with a decrease in gene expression.
Very little research has been done investigating DNA methylation changes after AMPH
treatment, although one study did find global DNA methylation increases in nucleus accumbens,
orbital frontal cortex, and medial prefrontal cortex following drug withdrawal after 14 days of
chronic AMPH treatment [30].
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Figure 4: Epigenetic mechanisms altered by AMPH
Caenorhabditis elegans as a Model Organism
Caenorhabditis elegans (C. elegans) has long been used as a model organism to study a variety
of topics as they provide a number of advantages over other model organisms. C. elegans is a
hermaphroditic nematode normally found in soil, and feeding on bacteria. C. elegans have a
relatively short life span, going from embryos to reproducing adults in a matter of 5 days. This
makes them ideal in studying long-term and transgenerational effects as studies can be
completed in a matter of a week or two, when similar studies in mammals would take months.
Because C. elegans feed on bacteria and each animal can produce 200-300 embryos, these
animals can be grown in large numbers easily on agar plates seeded with bacteria, leading to
large sample sizes in studies.
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The nervous system in C. elegans consists of 302 neurons, 8 of which are dopaminergic neurons.
Additionally, the connectome, which maps neurons connected to each other, has been mapped in
these animals, thus providing a great resource for studying their nervous system[31]. The
endogenous function of dopamine within these animals is to control movement [32]. As the
animal moves across a lawn of bacteria they get a release of dopamine, which has a downstream
effect of slowing the animal, thus keeping them on the food source for longer.

Previous studies in C. elegans have proven them as a valuable resource in studying
psychostimulant drugs that act on dopamine release [33-35]. Numerous studies have investigated
a now well-characterized behavioral test known as Swimming Induced Paralysis (SWIP)	
  [34]	
  
[33, 36-40]. For this behavioral test, the animals are submerged in fluid, where normally they
display a thrashing or swimming behavior, but in the presence of a substance that causes
dopamine release they paralyze. This paralysis happens in a dose and time dependent manner,
and has been attributed to an increase in dopamine within the synaptic cleft [33, 34].

C. elegans are also an excellent model for studying epigenetic mechanisms. The histone proteins
of C. elegans are highly homologous to histones of mammals [41-43] with a histone 3 and
histone 4 being 97% and 98% identical respectively in amino acid sequence to mammalian
histones. Due to the close conservation of these histone proteins they are likely to be modified in
the same manner [44, 45]. However, C. elegans do not methylate DNA similar to mammals. In
mammalian cells, the DNA is methylated on the fifth position of cytosine (5mC), which has not
been seen in C. elegans. One recent study however, has shown evidence of adenine N6
methylation (6mA), which was shown to have transgenerational effects in animal phenotype
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[46]. The finding of DNA methylation in C. elegans is still very recent and its role needs further
research.

EXPERIMENTAL METHODS
Maintenance of C. elegans
The C. elegans strain N2 was used in all studies. Animals were kept at 20°C and were plated on
agar plates seeded with E. coli (NA22 strain).

Amphetamine treatment of C. elegans
C. elegans embryos were treated overnight for 15 hours in AMPH. Plates full with adult animals
containing embryos were washed with water and collected in 15mL tubes. Tubes were spun
down at 12,000 rpm and washed several times to clear bacteria. Following the last wash, animals
were lysed by adding 2mL of bleach and 0.5mL of 10 N NaOH to the animals, and tubes were
filled to 10mL with water. Animals were rocked in this solution for 3 minutes. After the 3
minutes, the tube was filled with egg buffer to stop the reaction, and then washed 3 times with
egg buffer. Embryos were separated from debris using a sucrose solution. To do this egg buffer
was pulled off from the pellet and 5mL of 60% sucrose was added then filled with water up to
10mL in the tube. The pellet was disrupted and was shaken to mix well and then spun at 12,000
rpm for 6 minutes. Following centrifugation, eggs floated at the solution meniscus and a sterile
pipette was used to transfer eggs to a new tube and washed 3 times with water. The pellet was
then resuspended in 10mL of M9 solution. 4.975mL of this solution was separated into two new
tubes. One tube was used for the M9 control; the other tube had 25µL of 500mM AMPH added
for a final concentration of 500µM AMPH. Tubes were then rocked overnight for 15 hours at
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room temperature. Following the overnight incubation animals were washed 4 times with water,
and then plated on agar plates seeded with E. coli and allowed to grow until behavioral tests were
performed.

SWIP behavioral test
For this test 10-15 animals are collected with a platinum wire and placed into 40µl of 200mOsml
sucrose solution with or without 500µM AMPH for 10 minutes with the number (%) of
paralyzed animals recorded at minute intervals.

Primary cell culture of C. elegans embryos
Embryos were treated for 15 hours in either M9 solution or AMPH solution using the same
method as for SWIP testing. The embryos were washed and plated following the 15 hours and
allowed to grow to adults containing embryos of the F1 generation. The F1 generation embryos
were gathered using the same bleach/NaOH procedure as in AMPH treating process. Embryos
were separated from debris and washed with water. After last wash, water was removed and
embryos were moved to 2 mL tube with 1 mL chitinase solution (1 U per ml). Embryos were
incubated in chitinase solution at room temperature on a tube rotator. Incubation was carried out
for approximately 1 hour or until 80% of embryos have their eggshell digested. Tubes were
centrifuged at 3800 rpm for 3 min. Solution was then aspirated off and 1 mL of L-15 media
(Leibovitz’s L-15 media with 10% fetal bovine serum, 10 U ml-1 penicillin and 50 µg ml-1
streptomycin adjusted to 340 ± 5 mOsm) was used to resuspend the pellet. Repetitive pipetting
was used to dissociate the cells by pipetting against the side of the tube 60 times then
centrifuged. Solution was again aspirated off and 1 mL of L-15 was added then pipetting was
	
  

13	
  

repeated approximately 30 more times while periodically checking the progress of dissociation.
Progress of dissociation was check by eye and when the majority of embryos were dissociated
the tubes were again centrifuged, solution aspirated, and 1 mL of L-15 was added. Next the
solution was filtered to remove hatched larvas, clumped cells, or undissociated embryos. 1 mL of
L-15 media was put through 5 µm filters into 15 mL tube, followed by .5 mL of cell suspension
and 2 mL of L-15. Solution was pushed through filter and filter was washed twice with 2 mL of
L-15. Process was repeated with a new filter to filter the rest of the cell suspension. 15 mL tubes
with cell suspension were then centrifuged at 3800 rpm for 3 minutes. Following centrifugation
solution was aspirated until 5 mL of solution remained and pellet was resuspended. Cell counting
was done by taking an aliquot of cell suspension and making a 10x dilution. 10 µL of this
dilution was then added to 10 µL of trypan blue and loaded into cell counting slide for Countess
Automated Cell Counter (Invitrogen). Following cell counting, cells were plated onto peanut
lectin treated coverslips at 2 million cells per plate. The next morning after cells settled an
additional 1 mL of L-15 media was added to cells. Peanut lectin treated coverslips were created
the day before the procedure. First coverslips were sterilizing by placing in ethanol and flaming.
Then 400 µL of peanut lectin (.5 mg ml-1) was spread on the coverslip and allowed to incubate
for 30 minutes. Peanut lectin was then aspirated off and plates were left under UV light
overnight.

DA uptake assays in primary cell culture of C. elegans embryos
Uptake assays were carried out 4 days after primary cell preparation. For the uptake assay cells
were washed with 1 mL bath solution (145 mM NaCl, 5mM KCl, 1 mM CaCl2, 5 mM MgCl2,
10 mM HEPES, 20 mM D-Glucose, pH 7.2, 350 mOsm) 3 times, followed by incubation with
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5nM [3H] DA in bath TAP (bath solution with 100µM of each ascorbic acid, tropolone, and
pargyline) for 5 minutes with or without 10µM Imipramine present. Cells were then washed 4
times with 1 mL ice cold bath TAP solution. Lastly 500 µL 1% Triton-X was added and allowed
to incubate for 10 minutes to lyse cells. Supernatant was collected and 8 mL scintillation cocktail
(Research Products International Corp., Econo-Safe Biodegradable Counting Cocktail) was
added before counting in scintillation counter (Beckman Coulter LS 6500 multipurpose
scintillation counter).

Efflux assays in primary cell culture of C. elegans embryos
Efflux assays were carried out 4 days following primary cell preparation, using the same
preparation method as for uptake assays. Medium was removed from the cells and washed 3
times using bath solution. 1mL of 5nM [3H]DA diluted in bath TAP solution was then added to
cells and allowed to incubate at 30 minutes at room temperatures. To test [3H]DA loading, some
dishes were then washed 3 times with bath TAP and lysed with 500µL 1% Triton-X for 10
minutes. The solution was then collected in scintillation vials and 8mL scintillation cocktail was
added. All other dishes were washed 3 times with bath TAP solution. Then 1mL of 10µM
AMPH diluted in bath TAP solution was added to the dish and allowed to incubate for varying
times (1, 5, or 10 minutes). Solution was then collected in scintillation vials, following collection
of solution dishes were washed with 1mL of bath TAP and 500µL of 1% Triton-X was added for
10 minutes. After 10 minutes lysed solution was collected in scintillation vials to measure the
amount of DA still in cells. 8mL of scintillation cocktail was then added to all vials and counted
in scintillation counter.
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SH-SY5Y cell culture
SH-SY5Y cells are a human neuroblastoma cell line originally derived from bone marrow [47].
These cells have many characteristics of dopaminergic cells as they have been reported to
express the dopamine transporter [48-50], tyrosine hydroxylase[50], and dopamine-betahydroxylase[49]. The cells were grown in T75 flasks at 37°C and 5% CO2 in Dulbecco’s
Modified Eagle’s Medium (DMEM), which was prepared by adding 50% Fetal bovine serum
(FBS) and 1% Penicillin and Streptomycin solution in 500mL DMEM. Cells were passaged at
90% confluence. To passage cells they were first washed twice with sterile phosphate buffer
saline (PBS). After PBS was aspirated following second wash 2mL of 1X trypsin was added to
flask and incubated at 37°C for 5 minutes. Following incubated PBS was used to resuspend the
cells and move them into 15mL tubes. Cells were then pelleted by centrifugation at 1500rpm for
5 minutes at 4°C. Two more washes using PBS were done using the same pelleting procedure.
After the final wash cells were resuspended in DMEM and passaged into new T75 flasks
containing 15mL of DMEM.

DA uptake using SH-SY5Y cell line
For uptake assays using SH-SY5Y cells, cells were detached using the same procedure as for
passage and counted using Countess Automated Cell Counter. 150,000 cells were plated per well
in 6 well plates with 2mL DMEM. 24 hours later AMPH was added to half the well at 50µM
final concentration and given 15 hours to incubate. After AMPH exposure cells were washed
twice with 2mL of PBS and then fresh DMEM was added. 5 days later uptake experiments were
performed after insuring the cells had crossed a generation.
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Uptake assay was carried out similar to the procedure in primary cell culture. Cells were washed
with 1mL room temperature Krebs-Ringer HEPES (KRH) buffer 3 times. Then cells were
incubated with [3H]DA in KRH TAP (KRH + tropolone, ascorbic acid, and pargyline). The DA
was in a 1 part hot ([3H]DA) to 9 parts cold DA mixture, To obtain a final concentration of 1, 10,
50, 100, and 500nM; each concentration done in triplicate. Additionally in duplicates the
experiment was performed in wells in which the KRH TAP solution DA was incubated in
contain the inhibitor GBR 12935 at 10µM for control of non-specific binding and uptake.
Following the 5-minute incubation with DA, wells were washed with 1mL ice-cold KRH TAP
buffer 3 times, then lysed with 500µL of 1% Triton-X for 5 minutes. The solution was then
collected into scintillation vials and 8mL of scintillation cocktail was added before taking to
count in scintillation counter.

Quantitative reverse transcription PCR (RT –qPCR)
Embryos were treated with either M9 (control) or 500µM AMPH in M9 using the same
procedure that was used for behavioral analysis. RNA extraction was done on L1 and L4 stage
animals. First, animals were collected from plates and washed until no bacteria was present,
followed by two washes in nuclease free water. After final wash, animals were pelleted and
supernatant was removed, then 1mL of Trizol reagent was added and tube was shook for 90
seconds to lyse animals. Following 90 seconds on shaker tubes were vortexed and allowed to sit
at room temperature for 10 minutes, then moved to 4°C for 10 more minutes. Next 200µL of
chloroform was added and tubes were shook for 45 seconds followed by 3 minutes at room
temperature. Tubes were then centrifuged for 12,000rpm for 15 minutes at 4°C. After
centrifugation the aqueous phase was transferred to new 1.5mL tubes and 500µL of isopropanol
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was added and mixed by inverting the tubes. Then tubes were incubated 10 minutes at room
temperature and centrifuged at 12,000rpm for 10 minutes at 4°C. Solution was then discarded
and pellet was allowed to dry. 1mL of 75% ethanol was added to resuspend the pellet and
solution was moved to RNeasy column where manufacturer instructions were followed. Column
was spun at 12,000rpm for 30 seconds at 18°C, and flow through was discarded. 700µL of RW1
buffer was used to wash column, followed by two washes with 500µL of RPE buffer. Column
was then moved to a new collection tube and spun for 2 minutes to dry. Lastly the column was
moved to its final collecting tube and 30µL of nuclease free water was added to center and
allowed to incubate for 1 minute before final 90 second spin to elute RNA. RNA was run on
1.5% agarose gel after every collection to insure good quality. SYBR Safe DNA Gel Stain was
used to image RNA, and NanoDrop 2000c was used to quantify RNA.

Reverse transcriptase reactions were carried out using iScript Reverse Transcription Supermix.
Reactions were done by manufacturer’s specifications, specifically 100ng of RNA was mixed
with 4µL of iScript RT Supermix and nuclease free water was used to reach a final volume of
20µL. Reaction consisted of 3 cycles, priming for 5 minutes at 25°C, reverse transcription for 20
minutes at 46°C, and lastly RT inactivation for 1 minute at 95°C.

Following reverse transcription reaction a preamplification reaction was carried out. This
reaction was necessary because without it some genes (specifically DAT) were expressing too
low to be reliably quantified during quantitative real-time PCR. SsoAdvanced PreAmp Supermix
was used to carry out the preamplification reaction. Manufacturer instruction were followed the
reaction, 12.5µL of SsoAdvanced PreAmp Supermix was combined with 6.25µL of a primer
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pool made from the same primers used later in the quantitative real-time PCR reaction. Lastly
1.25µL of nuclease free water and 5µL of cDNA product were added. The reaction was carried
out as follows, 3 minutes at 95°C for polymerase activation, 15 seconds at 95°C for denaturation,
4 minutes at 58°C for annealing/extension. The denaturation and annealing/extension were
repeated for 12 cycles. A 10X dilution of the cDNA was done after the reaction.

The next day the real-time quantitative PCR was performed. A master mix was made with 5µL
of SsoAdvanced Universal SYBR Green Supermix, 1µL of respective primer, and 2µL of
nuclease free water, per well. 8µL of master mix was added to each well, followed by 2µL of
10X diluted cDNA product from PreAmp reaction. Reaction procedure was as follows. 95°C for
3 minutes, followed by 41 cycles of 95°C for 10 seconds and 60°C for 30 seconds. Lastly 98°C
for 10 seconds and 65°C for 31 seconds followed by a melt curve from 65°C to 95°C. Data was
analyzed using the 2-ΔΔCt method. For this method the average Ct value of actin (control) for each
sample was calculated. Then each Ct value for gene of interest was subtracted by the actin Ct
value average. The product of that subtraction was then subtracted by the average of the
“calibrator” (F0 generation M9 sample). Lastly that value named target-calibrator was taken as 2x

where X represents the target-calibrator value. The final value represents fold change with

respect to the “calibrator” in my experiments being the F0 generation M9 sample.

Western blots
Proteins were prepared from L4 stage animals following the same control vs. AMPH treatment
protocol used in behavioral testing. Once animals were L4 stage they were collected into 15mL
tubes and washed until cleaned of bacteria. Animals were then transferred to 1.5mL tubes and
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washed twice with TNET buffer. Following washes with TNET animals were pelleted and put in
TNET buffer with protease inhibitors, and then tubes were placed at -80°C for 10 minutes. Tubes
were removed from -80°C and put on ice. Sonication of the samples was then carried out using a
sonication wand in 10-second intervals 3 times. The wand was washed between each use and
tubes were placed back on ice to prevent heating. After sonication was complete the tubes were
centrifuged at 12,000rpm for 15 minutes at 4°C. Supernatant was collected after centrifugation
into fresh 1.5mL tubes and placed at -80°C for storage.

Protein concentrations were determined by Bradford assay using NanoDrop 2000c with cuvettes.
BSA in TNET was used to create a standard curve; each sample was then run to determine
concentrations.

The SDS-PAGE procedure was run on gels with a resolving gel of 12% polyacrylamide and a
5% polyacrylamide stacking gel. 20µg of protein was run for each sample, and samples were
mixed with standard loading buffer consisting of 5% 2-mercaptoethanol and boiled at 95°C for 5
minutes. Gels were run in 1X SDS page running gels at 140 volts for approximately 2 hours. The
gels were then transferred to PVDF membranes, in 1X transfer buffer. Transfer was performed at
300mA for 1 hour.

Following transfer membranes were blocked using a 3% BSA in TBST solution for 1 hour. After
blocking the membrane primary antibody was applied in a 1:1000 ratio and membrane was
allowed to rock overnight at 4°C. The next morning primary antibody was removed and the
membrane was moved into secondary antibody at 1:5000 ratio in TBST + 5% skim milk for 1
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hour. 6 washes were then performed for 10 minutes each using TBST. Following the last wash
membranes were treated with 1.5mL of Immun-Star AP Chemiluminescent Protein Detection
Systems for 2 minutes. Membranes were then imaged on Omega Lum G Imaging System, and
Photoshop was used for quantifying.

Materials used
Reagents
1X Transfer buffer (25 mM Tris, 192 mM glycine, 0.1% SDS, 20% methanol). SDS-PAGE 10X
gel running buffer (248 mM Tris, 1.92 M glycine, 1% SDS); Phosphate Buffer Saline (1.37 M
Sodium chloride, 2.7 mM Potassium chloride, 100mM disodium phosphate, 18mM potassium dihydrogen phosphate, pH 7.4). Krebs-Ringer HEPES buffer (116 mM Sodium chloride, 4mM
Potassium chloride, 1mM Magnesium chloride, 1.8 mM Calcium chloride, 25 mM Glucose,
10mM Hepes, pH 7.4).

Glucose and AMPH were from Sigma Aldrich (St. Louis, MO); Sucrose, Dimethyl Sulfoxide
(DMSO), HEPES, EDTA, Protease Inhibitor Tablets, Tween-20, Triton X- 100, BSA, Sodium
Phosphate, Potassium Chloride, Sodium Chloride, Disodium Phosphate, Calcium Chloride,
Potassium Dihydrogen Phosphate, SDS, Methanol, Glycine, β-Mercaptoethanol, Tris-HCl, and
PVDF membranes were from Fisher Scientific (Waltham, MA); Trypsin was from Corning
Cellgro (Manassas, VA); FBS was from Atlanta Biologicals (Atlanta, GA); DMEM and
Penicillin/Streptomycin were from Thermo Fisher Scientific (Waltham, MA); Alkaline
phosphatase substrate (ImmunStar) was from Bio-Rad (Hercules, CA).
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Equipment
Disintegration per minute (DPM) and counts per minute (CPM) of [3H] dopamine were
determined using LS 6500 multi-purpose scintillation counter from Beckman. Weight measuring
of chemical reagents was done on analytical balance from Ohaus. SH-SY5Y cells were
maintained in a Nuair 2700-30 water-jacketed CO2 incubator and splitting, plating and treatment
of cells was carried out in Nuair class II type A/B3 class II biological safety cabinet laminar flow
hood. Centrifugation was done using an Eppendorf micro centrifuge 5424R and Eppendorf
5810R centrifuge. SDS-PAGE and protein transfer to PVDF membranes during western blots
was completed using Mini-Protean tetra electrophoresis apparatus and Mini trans-blot
electrophoretic transfer cell from Bio-Rad. Power supply for SDS-PAGE and protein transfer
was Bio-Rad powerpac 300. Power supply for RNA gels was Bio-RAD powerpac 3000. Omega
LumTM G Imaging system was used for imaging PVDF membranes. Blots were quantified using
Adobe Photoshop software. Graphpad Prism software was used for all statistical analyses.

RESULTS
Embryonic exposure to AMPH in C. elegans leads to increased behavioral response to AMPH in
adult animals and their progeny
Whereas AMPH is a highly prescribed and abused drug, very little research has been done to
investigate the long-term effects of the drug as well as any trans-generational effects. C. elegans
have been previously used to investigate the molecular effects of AMPH on the dopaminergic
system due to their unique behavioral response but no studies have investigated the long-term
effect of the drug on the animals.
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Here C. elegans were used to generate a model of both the long-term and trans-generational
effects of embryonic AMPH exposure (Figure- 5). C. elegans embryos were gathered and were
exposed to the M9 solution alone (control) or M9 + 500µM AMPH for 15 hours while rocking at
room temperature. Following drug exposure all animals were washed and plated on agar plates
seeded with E. coli, this generation was labeled F0. Three days later, when animals reached
young adult stage the behavioral test known as swimming induced paralysis (SWIP) was
conducted to investigate their response to AMPH. We found that the animals exposed to AMPH
during embryogenesis had a greater response when challenged with 500µM of AMPH later as
young adults (Figure- 6A).

Some plates of F0 animals were not used for behavioral testing and were allowed to grow to full
adulthood when they contained embryos. The embryos of these animals were collected to create
the F1 generation using the same procedure as when collecting for AMPH exposure, with the
exception that no animals were treated in the F1 generation. All embryos were immediately
plated and allowed to grow to the L4 stage. Remarkably even though animals in the F1
generation had no previous contact with AMPH, when challenged with AMPH at the L4 stage
the progeny of animals exposed to AMPH as embryos showed higher response to the drug during
the SWIP test (Figure- 6B). To our knowledge this is the first demonstration of a transgenerational effect of AMPH.
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Figure 5: Experimental paradigm for AMPH exposure and SWIP behavioral test
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Figure 6: AMPH exposure during embryogenesis leads to increased AMPH induced SWIP both
in the generation of exposure as well as their progeny. Animals exposed to AMPH as embryos
(red squares) displayed higher SWIP response to AMPH with respect to animals treated with
control solution (blue circles) (A). Additionally in the F1 generation (B) the progeny of animals
exposed to AMPH (red squares) displayed higher SWIP response to AMPH, with respect to the
progeny of animals treated with control solution (blue circles). No difference in SWIP was
observed between M9 and AMPH exposed animals that were not challenged with AMPH (light
grey triangles and dark grey inverted triangles, respectively). Statistical analysis was two-way
ANOVA with Bonferroni’s Multiple Comparison test, P<0.05, using Graphpad Prism software
version 5.04.
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Embryonic AMPH exposure in F0 generation leads to reduced DA uptake in primary cell culture
of F1 generation
Previous studies have characterized the mechanisms causing the SWIP behavior in C. elegans.
These studies have found that an increase in DA within the synaptic cleft leads to paralysis [34],
and a mutation that alters the dopamine transporter, D2-like dopamine receptors, or synthesis and
packaging of DA, will alter AMPH induced paralysis in the animals [33].

Because previous studies have identified the dopamine transporter as a key player in the SWIP
behavior [33, 34, 36], and reverse transporter through the dopamine transporter is how AMPH
causes its effects, alterations in the ability of the dopamine transporter to uptake dopamine was
explored as a potential mechanism for the altered behavioral response to AMPH. To accomplish
this F0 animals were treated with either control (M9) or AMPH using the same procedure as in
behavioral testing, except all animals were allowed to grow to adults containing embryos (F1
generation). Embryos were collected to generate a primary cell culture containing all the cells
that would have continued on to create the F1 generation animals, including the dopaminergic
neurons. After 4 days, when the DA neurons exhibit axon and dendrite processes, DA uptake
assays were done using radiolabeled [3H]DA. [3H]DA was applied to the cell cultures for 5
minutes, after which cells were washed and lysed to measure [3H]DA content that was
transported into the cells. This assay allows for the investigation of any variation in the F1
animals ability to uptake DA through the dopamine transporter, either through changes in
transporter function or total number of transporter. Interestingly, the cell culture that was made
from the progeny of F0 generation animals exposed to AMPH as embryos showed a decreased
DA uptake of 45.7% with respect to control cultures (Figure 7). This assay indicates that the
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previous AMPH exposure in the F0 lead to the F1 generation having a reduced ability to uptake
DA. However, the assay does not indicate whether there are fewer transporters at the surface to
uptake DA, or if the transporter that is present has a reduced ability to uptake DA. This does
however give a potential mechanism by which the progeny of animals treated with AMPH as
embryos show an increased SWIP response.
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Figure 7: Embryonic AMPH exposure leads to reduced DA uptake in primary cell cultures of F1.
DA uptake in primary cell cultures made from embryos of the F1 generation reveal a reduced
DA uptake (45.7%) in the cultures made from the progeny of animals exposed to AMPH as
embryos (AMPH) with respect to the progeny of animals exposed to control solution (M9).
10µM imipramine was used to calculate only specific uptake through DAT. Statistical analysis
was students t-test, p<0.05, using Graphpad prism software version 5.04.
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DA Efflux is not altered in primary culture following embryonic AMPH exposure
AMPH causes the increase in DA within the synaptic cleft by reverse transport of the dopamine
transporter. Because of the reduced uptake ability of F1 cultures following AMPH exposure of
the F0 generation, DA efflux from AMPH treatment was investigated. Here primary cultures
were made using the same procedure as with the uptake assay, and efflux assays were carried out
by incubating the cells with 5nM radiolabeled [3H]DA 30 minutes. To insure there was no
difference in [3H] preloading between groups separate dishes were washed and lysed
immediately after loading. All other samples were washed out to remove extracellular [3H]DA
and 10µM AMPH was applied for 1, 5, or 10 minutes. Following AMPH incubation,
extracellular solution was collected and measured for [3H]DA content. Cell dishes were then
washed and lysed to check the amount of [3H]DA still within the cells.

The results of the efflux assay demonstrated that there was no difference in efflux caused by
AMPH after 1, 5, or 10 minutes of AMPH treatment (Figures- 8A, 8B, 8C, respectively).
Additionally after 30 minutes of preincubation with [3H]DA there was no difference in the
amount of [3H]DA present in the cell before AMPH treatment (Figure- 8D). This was indicated
both by having no difference in loading checked after the 30 minute preincubation (Figure- 8D).
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Figure 8: Embryonic AMPH exposure does not alter AMPH induced DA efflux. Efflux assays
using primary cell cultures made from the F1 generation progeny of animals either exposed to
AMPH (AMPH) as embryos, or control solution (M9) as embryos show there is no difference in
efflux after (A) 1, (B) 5, or (C) 10 minutes of AMPH treatment. Additionally at none of the
measured time points was there any change in lysate DA concentration, suggesting no difference
in total DA loaded before AMPH treatment. To further test DA loaded, DA was also measured
following the 30-minute pre-loading period (D). No difference was found between groups.
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AMPH exposure reduces uptake in SH-SY5Y cells
Results of the uptake assay in primary cell culture showed that there was a reduced ability of F1
animals to uptake DA. This could be attributed to either a reduced function of the dopamine
transporter or a reduced amount of the protein, or both. To further investigate these two
possibilities, uptake assays were carried out using a concentration response curve. Unfortunately
because C. elegans primary cell cultures required a large number of cells to produce a strong
signal in [3H]DA uptake assays it has the restriction of providing a limited number of cell dishes
to work with, which does not allow for a concentration response assay to be carried out. To
circumvent this problem SH-SY5Y cells were used for the uptake. These cells are a human
neuroblastoma cell line which has numerous characteristics found in dopaminergic cells. They
have been reported to express tyrosine hydroxylase [50], dopamine-beta-hydroxylase [49], and
most importantly the dopamine transporter [48-50].

150,000 SH-SY5Y cells were plated in 6 well plates and were exposed to 50µM AMPH for 15
hours, similar to that done in experiments with C. elegans. After AMPH exposure cells were
washed and allowed to grow for 5 days. Uptake assays were then carried out using a
concentration response curve of [3H]DA. Additionally, in some wells the assay was performed in
the presence of 10µM of GBR 12935, a compound that blocks DA uptake through DAT. These
wells were used to determine non-specific uptake, and was subtracted from total DA uptake.

The results from the concentration response curve showed that previous exposure to AMPH
leads to a decreased ability to uptake DA (Figure 9) and is similar to the effect seen in primary
cell culture (Figure 7). Michaelis-Menten kinetics were calculated from the concentration
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response curve and indicated that previous exposure to AMPH leads to a decrease in Vmax
(0.446 pM/min/1000cells ± 0.0328 for control, and 0.2596 pM/min/1000cells ± 0.0280 for
AMPH), with no change to Km (10.23nM ± 4.261 for control, and 14.37nM ± 7.933 for AMPH).
The Michaelis constant (Km) is the concentration at which the reaction is at half Vmax, and a
change in this value would indicate an altered apparent affinity of the transporter, however no
change was observed indicating that there was no alteration in transporter function. Vmax
represents the maximum rate at which the transporter can move substrate, which was decreased
by AMPH exposure. These results suggest that in the SH-SY5Y cells, like in C. elegans
embryonic cells, the previous AMPH exposure lead to a decreased number of DAT 5 days after
AMPH treatment was terminated.

The reported Km values for dopamine transport by DAT range from 460nM [51] to 2540nM
[52]. The Km values in our experiment for dopamine uptake in SH-SY5Y cells (10.23nM for
control, 14.37nM) for AMPH is lower than what has been previously reported. However, the SHSY5Y is a neuronally derived cell line and, therefore, is likely to express the appropriate DATinteracting proteins and more closely mirror the regulatory events that occur in dopaminergic
neurons. These components may be absent in other cell lines. SH-SY5Y cells have also been
shown to have characteristics of noradrenergic cells [53], such as norepinephrine uptake [54],
and our lab has previously shown SH-SY5Y cells transport dopamine through the norepinephrine
transporter (NET) [55]. Importantly, the concentration of inhibitor used to determine specific
uptake (GBR 12935 at 10µM) was sufficient to inhibit both the dopamine (Ki = 21.5 nM) and
norepinephrine transporters (Ki = 225 nM) [56]. Therefore, the concentration of GBR 12935
used in our SH-SY5Y experiments do not allow for distinction between transport of dopamine by
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DAT or NET, thus, our observed Km value likely represents mixed contributions of dopamine
uptake by both the DAT and NET transporters.
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Figure 9: Previous AMPH exposure leads to a reduction in Vmax in SH-SY5Y cells line. Uptake
assay with concentration response curve of DA in SH-SY5Y cell line revealed that previous
AMPH exposure leads to decreased DA uptake. Michaelis-Menten kinetics shows a reduced
Vmax (0.446 pM/min/1000cells ± 0.0328 for control, and 0.2596 pM/min/1000cells ± 0.0280 for
AMPH) following AMPH exposure, and no change in Km (10.23nM ± 4.261 for control, and
14.37nM ± 7.933 for AMPH). 10µM of GBR 12935 was used to calculate specific DA uptake
through DAT. Michaelis-Menten kinetics were calculated using Graphpad Prism software
version 5.04.
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Embryonic AMPH exposure leads to decrease DAT RNA in F1 generation
Results from the uptake assays pointed to the hypothesis that chronic AMPH exposure was
leading to a decreased expression of DAT. There are no commercial antibodies currently
available that target C. elegans DAT, thus measuring the protein itself would be very difficult.
However measuring the RNA amount of DAT is very practical using quantitative real-time PCR,
and could give us a greater insight into alterations in dat expression, with the caveat that RNA
expression changes do not directly correlate to changes in protein levels. C. elegans embryos
were exposed to AMPH from F0 and F1 generations using the same protocol for the SWIP
behavioral test. However, when animals reached L4 stage, RNA was collected via Trizol reagent
and processed using RNeasy Mini Kit. iScript reverse transcriptase was used to convert RNA to
cDNA. After several attempts of RT-qPCR it was discovered that the DAT gene was expressing
at too low of a level to be considered reliable when measuring. We hypothesized that the low
DAT readings were due to the fact that total RNA from whole animal was collected and DAT is
expressed only in 8-dopaminergic neurons out of 1031 total cells. To overcome this problem we
performed a PCR reaction after the reverse transcriptase reaction using SsoAdvanced PreAmp
Supermix. With this reaction the same primers were used as in the quantitative PCR, thus the
genes of interest were specifically amplified to allow a greater signal during the quantitative
PCR, allowing for more reliable Ct values. Quantitative PCR was carried out after the
preamplification reaction and results were calculated using the 2-ΔΔCt method, with the F0 M9
sample being used as the control sample.

The quantitative PCR demonstrated a decrease in dat-1 expression (32.6%) in the progeny of
animals that were exposed to AMPH during embryogenesis (F1 AMPH) with respect to the
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progeny of control animals (F1 M9) (Figure- 10). Surprisingly no difference was seen in the
expression of dat-1 in the F0 generation.
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Figure 10: A reduction in dat-1 RNA is seen in the F1 generation following F0 AMPH exposure.
dat-1 expression measured via quantitative reverse transcription PCR (RT –qPCR). F1
generation had a significant reduction in dat-1 expression in AMPH group with respect to M9
group. No difference was measured between M9 and AMPH groups within the F0 generation.
One-way ANOVA was used for statistical analysis with Bonferroni’s Multiple Comparison as
post-test, p<0.05, using Graphpad Prism software version 5.04.
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Western blots reveal a reduced level of histone 3 lysine 4 trimethylation in the F1 generation
The behavioral experiments along with uptake experiments demonstrate that AMPH exposure
has a long-term and transgenerational effect. This means the animals are retaining a cellular
memory of the previous exposure and this is in some way being transmitted to the next
generation of animals. Epigenetic mechanisms are thought to be the way through which cells can
hold a long-term cellular memory of previous exposure to drugs [23, 57, 58]. Moreover, it is
believed that epigenetics is responsible for drug exposure having an effect across multiple
generations [59, 60]. A number of epigenetic mechanisms could account for this. Histone
modifications were chosen for investigating in these experiments, specifically histone
methylation. Histone methylation was investigated because of previous implications in both
transgenerational inheritance [61] and AMPH effects [23].

Animals were exposed to AMPH using the same procedure as for behavioral experiments.
Following AMPH exposure animals were allowed to grow to the L4 stage, the same stage that
behavioral testing was carried out, and that RNA samples were collected. At L4 stage whole
animals were lysed and protein was collected. Initially, histone modification from whole animal
protein lysates were analyzed by western blot for a number of histone markers, which were
previously shown to be changed following treatment, and/or to be involved in transgenerational
inheritance [61].

Western blot experiments revealed a significant decrease in histone 3 lysine 4 trimethylation
(H3K4me3) (6.80%) (Figure- 11A) and histone 3 lysine 9 dimethylation (H3K9me2) (18.74%)
(Figure 11B) in the AMPH group of F1 generation with respect to M9 control. No change was
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seen in H3K4me3 or H3K9me2 in the F0 generation. Additionally the histone methylation
markers H3K9me3 (Figure- 11C), H3K27me3 (Figure 11D), and H3K36me2 (Figure 11E)
showed no difference in either F0 or F1 generation.
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Figure 11: Western blots reveal a reduction in H3K4me3 and H3K9me2 in the F1 generation.
Western blots of whole animal protein from L4 animals following AMPH exposure in the F0
generation and their progeny (F1 generation). H3K4me3 was reduced in F1 AMPH with respect
to F1 M9 (A), additionally H3K9me2 was reduced in F1 AMPH with respect to F1 M9 and
increase in F1 M9 with respect to F0 M9 (B). No change was observed in H3K9me3 (C),
H3K27me3 (D), or H3K36me2 (E). Statistical analysis used was one-way ANOVA and
Bonferroni’s Multiple Comparison test, p<0.05, using Graphpad Prism software version 5.04.
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AMPH exposure alters the levels of enzymes responsible for histone methylation
There are a number of enzymes that are responsible for either methylating or demethylating
histones. If the levels of these modifying enzymes are altered then the histone methylation status
will be changed, thus leading to either increased or decreased gene expression. In addition
changes in gene expression, which were correlated with alterations in histone methylation, have
been observed even after withdrawal of drugs of abuse [57]. Because a change in H3K4me3 was
observed (Figure- 11A) quantitative reverse transcription PCR (RT –qPCR) was used to
investigate the levels of enzymes responsible for methylation (set-16) of H3K4me2 and
demethylation (rbr-2) of H3K4me3. AMPH exposure was done in the same manner as all other
experiments, and RNA was extracted at L4 stage, same as in behavioral experiments. RNA was
then converted to cDNA using reverse transcriptase reaction, followed by quantitative PCR to
measure expression levels of the two enzymes of interest.

Quantitative PCR showed that both set-16 (Figure- 12A) and rbr-2 enzymes (Figure 12B) had
reduced expression in the progeny of AMPH exposed animals (F1 AMPH) (54.1% and 56.9%
respectively) with respect to the progeny of control animals (F1 M9). Neither set-16 nor rbr-2
showed any expression changes in the F0 generation.
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Figure 12: A reduction in RNA levels is observed in F1 of both the methyltransferase set-16 and
demethylase rbr-2 enzymes. RNA concentrations of histone modifying enzymes following
control or 500µM AMPH exposure in animals from F0 generation. In F1 generation set-16 was
decreased in expression in F1 AMPH with respect to F1 M9 (A). Additionally rbr-2 expression
was decreased in F1 AMPH with respect to F1 M9 (B). Statistical analysis was one-way
ANOVA with Bonferroni’s Multiple Comparison test, p<0.05, using Graphpad Prism software
version 5.04.
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DISCUSSION
While numerous studies have focused on the molecular mechanisms of AMPH, there is a large
gap in our knowledge of the long-term effects of the drug. Moreover even less research has been
done to investigate any transgenerational effects of AMPH exposure. This is alarming as AMPH
is widely prescribed for the treatment of ADHD, narcolepsy, and obesity. Moreover, the
treatment regimen of AMPH often requires patients to take the drug for prolonged periods of
time.

While AMPH can be successfully used to treat many diseases, it also carries with it the potential
for abuse. This abuse can stem from either prolonged use to treat disease or from illicit
recreational use. There are a number of reasons why people use AMPH recreationally. These
include as an appetite suppressant to help in losing weight, for the stimulant properties of AMPH
to combat fatigue, or as an aid in studying or tasks requiring an increase focus. The last of these
reasons is a major contributor to teenagers or young adults abusing AMPH.

The initial focus of these studies was to investigate if lasting effects of AMPH could be observed
and modeled in C. elegans behavior. Further, we asked whether any behavioral alterations would
be transmitted to future generations. We did in fact find that if animals were exposed to 500µM
of AMPH for 15 hours during embryogenesis, then washed of drug and allowed to grow to the
L4 stage, they displayed a increased sensitivity to AMPH at this later stage. Specifically, the
increased sensitivity was in the SWIP test. This behavioral test, in which animals are placed in
fluid and paralysis is measured, has been well characterized, and the paralysis displayed can be
attributed to increased DA levels within the synapse. For these experiments animals were
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challenged with 500µM of AMPH in the SWIP test. Animals with previous exposure to AMPH
had increased paralysis, thus these animals were either 1) releasing DA at a much faster rate, 2)
were unable to clear DA from the synapse as fast, or 3) had an alteration in D2-like receptors.
Using additional test cohorts that were not tested in the SWIP test we collected animals for the
next generation (F1), and no exposure was conducted with these animals. They were simply
plated and allowed to grow to the L4 stage. Once they reached L4 stage, the F1 generation was
also challenged with 500µM of AMPH in the SWIP test. Surprisingly, the progeny of animals
that were exposed to AMPH as embryos also displayed a higher SWIP response when challenged
with AMPH, with respect to the progeny of control animals. This result suggests that the F1
generation progeny of AMPH exposed animals were having a larger buildup of DA in the
synapse with respect to control animals, or some alteration to the D2-like receptors. These
experiments are the first to model an altered behavioral response in a transgenerational manner
following AMPH exposure.

Because of previous characterization of the SWIP response [33, 34], we can hypothesize that
dopaminergic transmission is altered by the AMPH exposure in F0 animals. It is well known that
AMPH exerts its actions through the DAT, thus to begin investigating potential mechanisms for
the behavioral alteration we did uptake assays to explore if there was any change in the uptake
ability of DAT. To examine this, F0 animals were exposed to 500µM of AMPH for 15 hours in
exactly the same way as for the behavioral assay. The F1 generation animals however were
isolated as embryos and used to create a primary cell culture. The assay revealed that cultures
prepared from the progeny of animals exposed to AMPH had reduced [3H]DA uptake with
respect to control cultures. This result provides a potential mechanism by which the increase in
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SWIP paralysis is observed. As mentioned above, AMPH exposure leads to increased levels of
DA in the synapse, and if the neurons are not as capable of clearing the DA out of the synapse
through DAT, then the animals will display increased paralysis. The uptake assay however does
not reveal exactly why there is reduced uptake of DA, as this could be attributed to either a
reduced amount of DAT total protein, or the number of DAT proteins present at the surface of
neurons, or it could be caused by unaltered amount of DAT protein, but with reduced function.
Further experiments were needed to reveal why the AMPH exposure lead to reduced uptake.

AMPH is well known to cause release of DA into the synapse by utilizing reverse transport of
DA through DAT. Because of this, we hypothesized that AMPH exposure could alter the efflux
rate of DA into the synapse in the presence of AMPH, which would then change paralysis rates.
The same F0 treatment paradigm and F1 primary cell culture protocol was followed as in the
uptake assays. Therefore efflux assays were performed, but they revealed no difference in DA
efflux between the 2 groups (control and AMPH exposed animals). Lysates of the cells following
release assays were also collected and measured for [3H]DA content. No difference was seen in
lysate [3H]DA concentration leading us to believe that there was no difference in the preloading
of [3H]DA after 30 minutes. Any difference in preloading could have an effect on the efflux
assay but our method suggested that this was not the case. This was surprising as after 5 minutes
of the uptake assays, we see a reduced uptake, but after 30 minutes of preloading of [3H]DA we
observe no difference. Our current hypothesis is that with the extended time cells have during
preloading, an equilibrium is reached, and thus both groups end up with similar intracellular
concentrations of [3H]DA.
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The uptake assay in primary cell culture showed that AMPH exposure in embryos of F0
generation was having an effect on DA uptake in F1 generation. However, as mentioned it does
not indicate if this was due to reduced DAT expression or reduced DAT function. One way to
further investigate the alterations in uptake is to perform concentration response experiments
using different concentrations of DA. Thus, we used the SH-SY5Y human neuroblastoma cell
line, which endogenously expresses DAT [48-50]. The cells were exposed to 50µM AMPH for
15 hours and then washed. Cells were allowed to grow and cross a generation, and 5 days later,
uptake assays were performed using concentrations of [3H]DA between 1 and 500 nM. The
inhibitor GBR 12935 (10µM) was used in some wells to inhibit uptake through DAT, allowing
for the subtraction of nonspecific background. Similar to the results shown in experiments with
C. elegans, a decrease in uptake was observed following AMPH exposure. Additionally, when
Michaelis-Menten kinetics were calculated from the concentration response curve, a decrease in
Vmax was observed in cells previously exposed to AMPH, with no change to Km. The results of
this would suggest a decrease in surface DAT but no change in the function of DAT.

To further investigate if the level of DAT was changing following AMPH exposure, quantitative
real-time PCR was carried out on animals at the same stage that behavior was tested (L4). The
PCR revealed that RNA levels for DAT were decreased in the progeny of animals exposed to
AMPH, with respect to control animals. Surprisingly no change was observed in samples from
F0 generation. These results agree with results seen in uptake assays in both the C. elegans
primary cell culture as well as the human SH-SY5Y line, and could explain a mechanism by
which we see the increased sensitivity in behavioral testing in the F1 generation. That
mechanism being that AMPH exposure decreases the dopaminergic neurons ability to reuptake
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DA, thus when AMPH causes increased DA within the synapse the animals are not able to clear
the DA as efficiently. This increased synaptic DA in turn explains the increased paralysis. The
lack of change in RNA in the F0 generation was unexpected, as the increased behavioral
sensitivity is seen in both F0 and F1. To further investigate this uptake ability of the F0
generation would need to be explored. Additionally the RNA levels of DAT could remain
unchanged and still have varied levels of DAT at the surface of neurons as the protein is
trafficked between the surface and intracellular storage and AMPH has been previously shown to
effect this cycle [62, 63].

These experiments have shown that embryonic exposure to AMPH is leading to a
transgenerational inheritance in increased behavioral response to AMPH, which uptake assays
and qPCR experiments suggest is due to reduced DAT expression in F1 generation. Our
hypothesis was that epigenetic changes could be responsible for the inherited changes, and we
therefore began by looking at histone methylation as a potential mechanism. Five histone
methylation markers were investigated using western blots. The 5 chosen histone modifications,
H3K4me3, H3K9me2 and me3, H3K27me3, and H3K36me2 were based on previous research in
epigenetics of drug abuse and previous research in transgenerational inheritance [57, 61].
Western blots revealed a significant decrease in histone 3 lysine 4 trimethylation (H3K4me3) in
the progeny of AMPH- exposed animals with respect to the progeny of control animals. A
significant decrease was also observed in histone 3 lysine 9 dimethylation (H3K9me2) also in F1
AMPH animals with respect to F1 M9 animals, and additionally a significant increase was seen
in F1 M9 animals with respect to F0 M9 animals. These results show that even when looking at
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whole animal protein lysates, the levels of epigenetic modifications were altered by AMPH
exposure.

Because changes in H3K4me3 levels were observed, quantitative real-time PCR was used to
investigate if RNA levels of the enzymes responsible for methylating and demethylating
H3K4me3 were varied. Our qPCR experiments revealed that both set-16, the enzyme responsible
for trimethylation of H3K4, and rbr-2, the enzyme responsible for removing the trimethylation
from H3K4, had reduced expression with in the progeny of AMPH exposed animals (F1 AMPH)
with respect to the progeny of control animals (F1 M9). These results suggest that remodeling is
occurring at the epigenetic level. However we cannot tell from these experiments in which cell
types the remodeling is occurring. Additionally, to identify where in the genome histone
methylation is altered chromatin immunoprecipitation experiments need to be performed.

Conclusion
AMPH is a psychostimulant that is both highly prescribed and highly abused, while the longterm effect of this is not well understood. Additionally studies in other drugs of abuse are
revealing that these substances may have effects that last across generations. Here we developed
a model to study the long-term effects of AMPH and we found that chronic AMPH exposure
during embryogenesis causes behavioral and functional change in adult animals and progeny.
Experiments to reveal the mechanism by which AMPH was causing altered behavioral response
to AMPH discovered that AMPH exposure during embryogenesis leads to reduced DA uptake
ability within primary cell cultures created from the next generation. Further exploration
revealed that reduced DAT expression was responsible for the reduced DA uptake, unveiling a
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mechanism by which AMPH was having the transgenerational effect on behavior. Furthermore
AMPH exposure was shown to alter histone methylation by acting through specific enzymes.
These experiments highlight the importance of continued research on AMPH and its effects on
dopaminergic transmission. Additionally consideration of these effects should be taken into
account when prescribing AMPH, as this drug is currently the first line of treatment for ADHD.

	
  

49	
  

REFERENCES
1.

Deumens R, Blokland APrickaerts J (2002) Modeling Parkinson's disease in rats: an
evaluation of 6-OHDA lesions of the nigrostriatal pathway. Exp Neurol 175: 303-17.

2.

Iwata K, Ikehara M, Kunimura YOzawa H (2016) Interactions between Kisspeptin
Neurons and Hypothalamic Tuberoinfundibular Dopaminergic Neurons in Aged Female
Rats. Acta Histochem Cytochem 49: 191-196.

3.

Taylor SB, Lewis CROlive MF (2013) The neurocircuitry of illicit psychostimulant
addiction: acute and chronic effects in humans. Subst Abuse Rehabil 4: 29-43.

4.

Elsworth JDRoth RH (1997) Dopamine synthesis, uptake, metabolism, and receptors:
relevance to gene therapy of Parkinson's disease. Exp Neurol 144: 4-9.

5.

McElvain JSSchenk JO (1992) A multisubstrate mechanism of striatal dopamine uptake
and its inhibition by cocaine. Biochem Pharmacol 43: 2189-99.

6.

Gu H, Wall SCRudnick G (1994) Stable expression of biogenic amine transporters
reveals differences in inhibitor sensitivity, kinetics, and ion dependence. J Biol Chem
269: 7124-30.

7.

Forrest LR, Zhang YW, Jacobs MT, Gesmonde J, Xie L, et al. (2008) Mechanism for
alternating access in neurotransmitter transporters. Proc Natl Acad Sci U S A 105: 1033843.

8.

Carvelli L, McDonald PW, Blakely RDDeFelice LJ (2004) Dopamine transporters
depolarize neurons by a channel mechanism. Proc Natl Acad Sci U S A 101: 16046-51.

9.

(2014) Stimulant ADHD medications; methylphenidate and amphetamines. National
Institute on Drug Abuse; National Institutes of Health; U.S. Department of Health and
Human Services.

	
  

50	
  

10.

Perez-Mana C, Castells X, Torrens M, Capella DFarre M (2013) Efficacy of
psychostimulant drugs for amphetamine abuse or dependence. Cochrane Database Syst
Rev: CD009695.

11.

Beuming T, Kniazeff J, Bergmann ML, Shi L, Gracia L, et al. (2008) The binding sites
for cocaine and dopamine in the dopamine transporter overlap. Nat Neurosci 11: 780-9.

12.

Jones SR, Gainetdinov RR, Wightman RMCaron MG (1998) Mechanisms of
amphetamine action revealed in mice lacking the dopamine transporter. J Neurosci 18:
1979-86.

13.

Sulzer D, Chen TK, Lau YY, Kristensen H, Rayport S, et al. (1995) Amphetamine
redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse
transport. J Neurosci 15: 4102-8.

14.

McCowan TJ, Dhasarathy ACarvelli L (2015) The Epigenetic Mechanisms of
Amphetamine. J Addict Prev 2015.

15.

Luger K, Dechassa MLTremethick DJ (2012) New insights into nucleosome and
chromatin structure: an ordered state or a disordered affair? Nat Rev Mol Cell Biol 13:
436-47.

16.

Shen HY, Kalda A, Yu L, Ferrara J, Zhu J, et al. (2008) Additive effects of histone
deacetylase inhibitors and amphetamine on histone H4 acetylation, cAMP responsive
element binding protein phosphorylation and DeltaFosB expression in the striatum and
locomotor sensitization in mice. Neuroscience 157: 644-55.

17.

Kalda A, Heidmets LT, Shen HY, Zharkovsky AChen JF (2007) Histone deacetylase
inhibitors modulates the induction and expression of amphetamine-induced behavioral

	
  

51	
  

sensitization partially through an associated learning of the environment in mice. Behav
Brain Res 181: 76-84.
18.

Moretti M, Valvassori SS, Varela RB, Ferreira CL, Rochi N, et al. (2011) Behavioral and
neurochemical effects of sodium butyrate in an animal model of mania. Behav Pharmacol
22: 766-72.

19.

Stertz L, Fries GR, Aguiar BW, Pfaffenseller B, Valvassori SS, et al. (2014) Histone
deacetylase activity and brain-derived neurotrophic factor (BDNF) levels in a
pharmacological model of mania. Rev Bras Psiquiatr 36: 39-46.

20.

Steckert AV, Valvassori SS, Varela RB, Mina F, Resende WR, et al. (2013) Effects of
sodium butyrate on oxidative stress and behavioral changes induced by administration of
D-AMPH. Neurochem Int 62: 425-32.

21.

Arent CO, Valvassori SS, Fries GR, Stertz L, Ferreira CL, et al. (2011) Neuroanatomical
profile of antimaniac effects of histone deacetylases inhibitors. Mol Neurobiol 43: 20714.

22.

Kim WY, Kim SKim JH (2008) Chronic microinjection of valproic acid into the nucleus
accumbens attenuates amphetamine-induced locomotor activity. Neurosci Lett 432: 54-7.

23.

Renthal W, Carle TL, Maze I, Covington HE, 3rd, Truong HT, et al. (2008) Delta FosB
mediates epigenetic desensitization of the c-fos gene after chronic amphetamine
exposure. J Neurosci 28: 7344-9.

24.

Graybiel AM, Moratalla RRobertson HA (1990) Amphetamine and cocaine induce drugspecific activation of the c-fos gene in striosome-matrix compartments and limbic
subdivisions of the striatum. Proc Natl Acad Sci U S A 87: 6912-6.

	
  

52	
  

25.

Deng JV, Rodriguiz RM, Hutchinson AN, Kim IH, Wetsel WC, et al. (2010) MeCP2 in
the nucleus accumbens contributes to neural and behavioral responses to
psychostimulants. Nat Neurosci 13: 1128-36.

26.

Rotllant DArmario A (2012) Brain pattern of histone H3 phosphorylation after acute
amphetamine administration: its relationship to brain c-fos induction is strongly
dependent on the particular brain area. Neuropharmacology 62: 1073-81.

27.

Nestler EJ, Barrot MSelf DW (2001) DeltaFosB: a sustained molecular switch for
addiction. Proc Natl Acad Sci U S A 98: 11042-6.

28.

Muschamp JW, Nemeth CL, Robison AJ, Nestler EJCarlezon WA, Jr. (2012) DeltaFosB
enhances the rewarding effects of cocaine while reducing the pro-depressive effects of
the kappa-opioid receptor agonist U50488. Biol Psychiatry 71: 44-50.

29.

Robison AJNestler EJ (2011) Transcriptional and epigenetic mechanisms of addiction.
Nat Rev Neurosci 12: 623-37.

30.

Mychasiuk R, Muhammad A, Ilnytskyy SKolb B (2013) Persistent gene expression
changes in NAc, mPFC, and OFC associated with previous nicotine or amphetamine
exposure. Behav Brain Res 256: 655-61.

31.

White JG, Southgate E, Thomson JNBrenner S (1986) The structure of the nervous
system of the nematode Caenorhabditis elegans. Philos Trans R Soc Lond B Biol Sci
314: 1-340.

32.

Sawin ER, Ranganathan RHorvitz HR (2000) C. elegans locomotory rate is modulated by
the environment through a dopaminergic pathway and by experience through a
serotonergic pathway. Neuron 26: 619-31.

	
  

53	
  

33.

Carvelli L, Matthies DSGalli A (2010) Molecular mechanisms of amphetamine actions in
Caenorhabditis elegans. Mol Pharmacol 78: 151-6.

34.

McDonald PW, Hardie SL, Jessen TN, Carvelli L, Matthies DS, et al. (2007) Vigorous
motor activity in Caenorhabditis elegans requires efficient clearance of dopamine
mediated by synaptic localization of the dopamine transporter DAT-1. J Neurosci 27:
14216-27.

35.

Nass R, Hahn MK, Jessen T, McDonald PW, Carvelli L, et al. (2005) A genetic screen in
Caenorhabditis elegans for dopamine neuron insensitivity to 6-hydroxydopamine
identifies dopamine transporter mutants impacting transporter biosynthesis and
trafficking. J Neurochem 94: 774-85.

36.

Carvelli L, Blakely RDDeFelice LJ (2008) Dopamine transporter/syntaxin 1A
interactions regulate transporter channel activity and dopaminergic synaptic transmission.
Proc Natl Acad Sci U S A 105: 14192-7.

37.

Hardaway JA, Sturgeon SM, Snarrenberg CL, Li Z, Xu XZ, et al. (2015) Glial
Expression of the Caenorhabditis elegans Gene swip-10 Supports Glutamate Dependent
Control of Extrasynaptic Dopamine Signaling. J Neurosci 35: 9409-23.

38.

Bermingham DP, Hardaway JA, Snarrenberg CL, Robinson SB, Folkes OM, et al. (2016)
Acute blockade of the Caenorhabditis elegans dopamine transporter DAT-1 by the
mammalian norepinephrine transporter inhibitor nisoxetine reveals the influence of
genetic modifications of dopamine signaling in vivo. Neurochem Int 98: 122-8.

39.

Felton CMJohnson CM (2014) Dopamine signaling in C. elegans is mediated in part by
HLH-17-dependent regulation of extracellular dopamine levels. G3 (Bethesda) 4: 1081-9.

	
  

54	
  

40.

Hardaway JA, Hardie SL, Whitaker SM, Baas SR, Zhang B, et al. (2012) Forward
genetic analysis to identify determinants of dopamine signaling in Caenorhabditis elegans
using swimming-induced paralysis. G3 (Bethesda) 2: 961-75.

41.

Vanfleteren JR, Van Bun SM, Delcambe LLVan Beeumen JJ (1986) Multiple forms of
histone H2B from the nematode Caenorhabditis elegans. Biochem J 235: 769-73.

42.

Vanfleteren JR, Van Bun SMVan Beeumen JJ (1987) The primary structure of histone
H3 from the nematode Caenorhabditis elegans. FEBS Lett 211: 59-63.

43.

Vanfleteren JR, Van Bun SMVan Beeumen JJ (1987) The primary structure of histone
H4 from the nematode Caenorhabditis elegans. Comp Biochem Physiol B 87: 847-9.

44.

Bender LB, Cao R, Zhang YStrome S (2004) The MES-2/MES-3/MES-6 complex and
regulation of histone H3 methylation in C. elegans. Curr Biol 14: 1639-43.

45.

Kelly WG, Schaner CE, Dernburg AF, Lee MH, Kim SK, et al. (2002) X-chromosome
silencing in the germline of C. elegans. Development 129: 479-92.

46.

Greer EL, Blanco MA, Gu L, Sendinc E, Liu J, et al. (2015) DNA Methylation on N6Adenine in C. elegans. Cell 161: 868-78.

47.

Biedler JL, Roffler-Tarlov S, Schachner MFreedman LS (1978) Multiple
neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res 38:
3751-7.

48.

Lopes FM, da Motta LL, De Bastiani MA, Pfaffenseller B, Aguiar BW, et al. (2017) RA
Differentiation Enhances Dopaminergic Features, Changes Redox Parameters, and
Increases Dopamine Transporter Dependency in 6-Hydroxydopamine-Induced
Neurotoxicity in SH-SY5Y Cells. Neurotox Res 31: 545-559.

	
  

55	
  

49.

Xie HR, Hu LSLi GY (2010) SH-SY5Y human neuroblastoma cell line: in vitro cell
model of dopaminergic neurons in Parkinson's disease. Chin Med J (Engl) 123: 1086-92.

50.

Presgraves SP, Ahmed T, Borwege SJoyce JN (2004) Terminally differentiated SHSY5Y cells provide a model system for studying neuroprotective effects of dopamine
agonists. Neurotox Res 5: 579-98.

51.

Eshleman AJ, Carmolli M, Cumbay M, Martens CR, Neve KA, et al. (1999)
Characteristics of drug interactions with recombinant biogenic amine transporters
expressed in the same cell type. J Pharmacol Exp Ther 289: 877-85.

52.

Giros B, Wang YM, Suter S, McLeskey SB, Pifl C, et al. (1994) Delineation of discrete
domains for substrate, cocaine, and tricyclic antidepressant interactions using chimeric
dopamine-norepinephrine transporters. J Biol Chem 269: 15985-8.

53.

Kume T, Kawato Y, Osakada F, Izumi Y, Katsuki H, et al. (2008) Dibutyryl cyclic AMP
induces differentiation of human neuroblastoma SH-SY5Y cells into a noradrenergic
phenotype. Neurosci Lett 443: 199-203.

54.

Balasooriya ISWimalasena K (2007) Are SH-SY5Y and MN9D cell lines truely
dopaminergic? Proceedings fo the 3rd annual GRASP symposium.

55.

Ferdous N (2016) Chronic amphetamine exposure causes long term effects on dopamine
uptake in cultured cells.

56.

Torres GE, Gainetdinov RRCaron MG (2003) Plasma membrane monoamine
transporters: structure, regulation and function. Nat Rev Neurosci 4: 13-25.

57.

Maze I, Covington HE, 3rd, Dietz DM, LaPlant Q, Renthal W, et al. (2010) Essential role
of the histone methyltransferase G9a in cocaine-induced plasticity. Science 327: 213-6.

	
  

56	
  

58.

Nestler EJ (2014) Epigenetic mechanisms of drug addiction. Neuropharmacology 76 Pt
B: 259-68.

59.

Pierce RCVassoler FM (2014) Reduced cocaine reinforcement in the male offspring of
cocaine-experienced sires. Neuropsychopharmacology 39: 238.

60.

Vassoler FM, Oliver DJ, Wyse C, Blau A, Shtutman M, et al. (2017) Transgenerational
attenuation of opioid self-administration as a consequence of adolescent morphine
exposure. Neuropharmacology 113: 271-280.

61.

Greer EL, Beese-Sims SE, Brookes E, Spadafora R, Zhu Y, et al. (2014) A histone
methylation network regulates transgenerational epigenetic memory in C. elegans. Cell
Rep 7: 113-26.

62.

Fleckenstein AE, Metzger RR, Wilkins DG, Gibb JWHanson GR (1997) Rapid and
reversible effects of methamphetamine on dopamine transporters. J Pharmacol Exp Ther
282: 834-8.

63.

Sandoval V, Riddle EL, Ugarte YV, Hanson GRFleckenstein AE (2001)
Methamphetamine-induced rapid and reversible changes in dopamine transporter
function: an in vitro model. J Neurosci 21: 1413-9.

	
  

57	
  

